Where Electrical Muscle Stimulation Came From
Medically reviewed by
4 independent reviewers
Andrew Conrad Barile, PT, DPT
Doctor of Physical Therapy (DPT) | Licensed Physical Therapist (PT) | CEO and Founder, Xtreem Pulse LLC
Read bio
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC, the engineering company behind PureLift. He earned his Doctorate in Physical Therapy from Daemen College and is a licensed physical therapist.
He brings over two decades of clinical and entrepreneurial experience across physical therapy, craniosacral therapy and medical device innovation, built on a working knowledge of human anatomy and muscle physiology.
For PureLift LAB he reviews how current is delivered across all ten levels, from sub-sensory nanocurrent and skin-level microcurrent to motor-level EMS, and how the Infuse pass fits into the same ten-minute routine.
Bertica M. Rubio, M.D.
Board-Certified Physician, Dartmouth Medical School | Medical Director, Antiaging Regenerative Medicine Clinic
Read bio
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Doctor of Medicine from Dartmouth Medical School and completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, she specialises in age management medicine, regenerative medicine, wound healing and growth factor therapies, and her practice integrates evidence-based medical science with advanced aesthetic treatment.
For PureLift LAB she reviews articles for medical accuracy across the whole dial, from the gentle nanocurrent and microcurrent settings through to muscle-level EMS and the Infuse pass.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist | Head and Neck Surgeon | Fellow, American College of Surgeons | Mount Sinai
Read bio
Daniel Grinberg, MD, FACS is a board-certified otolaryngologist and head and neck surgeon at ENT and Allergy Associates in West Nyack, New York. He earned his medical degree from Columbia University College of Physicians and Surgeons.
He completed his otolaryngology residency at New York University Medical Center, serves as Assistant Clinical Professor at Mount Sinai School of Medicine, and is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
For PureLift LAB he brings a wider clinical lens, connecting at-home facial stimulation from microcurrent to EMS to the anatomy underneath, with the same rigour we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology
Read bio
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital.
He trained at the University of Hamburg, was a Max Planck Society Fellow at the Max Planck Institute for Heart and Lung Research, and held senior consultant posts at the Charite Universitatsmedizin Berlin before his appointment as Chair in 2016.
One of Europe's leading authorities on arteriogenesis, with over 150 peer-reviewed publications and US and EU patents, he reviews for PureLift LAB how the evidence on electrical stimulation is read and where its limits lie.
Share
Electrical muscle stimulation was developed in clinical rehabilitation, where it is used to maintain muscle in people who cannot move it voluntarily.
This article covers what actually decides the answer, such as:
- The clinical origin
- Why that history does not transfer directly
- What the facial evidence actually says
- What the clinical lineage genuinely gives you
- How to read the claim when you see it
and many more!
It is not evidence for a facial device, and a brand borrowing the credibility without the caveat is doing something worth noticing.
Key Points:
Clinical NMES targets large limb muscles at outputs far above anything a facial device delivers.
Facial muscles are small, thin, and mostly attach into soft tissue rather than bone at both ends.
A rehabilitation result on a quadriceps does not transfer to a cheek.
The facial evidence has to come from facial studies, and there are some.
What the clinical history does give you is a well-characterised mechanism and decades of safety data on the underlying principle.
The clinical origin
Neuromuscular electrical stimulation is standard equipment in physiotherapy. It is used where a muscle cannot be worked voluntarily, after surgery, after injury, or where a nerve pathway is impaired, and the purpose is to slow or reverse the wasting that follows disuse.
The principle is straightforward: a nerve fires a muscle when the current reaches the motor threshold, and it does not much matter to the muscle whether the signal came from your brain or from an electrode. Ward's work sets out that threshold alongside the two below it (PMID 19095805).
Space medicine and sports rehabilitation both draw on the same principle for the same reason, which is that muscle unloaded for long periods does not stay the same.
Maffiuletti's work on evaluating NMES makes an important point from that field: the setting on the dial is not the same as the tension actually produced in the muscle (PMID 29233625).
Why that history does not transfer directly
A clinical NMES unit working a quadriceps operates at outputs far above anything a facial device delivers, through large electrodes, on a muscle several centimetres thick that attaches to bone at both ends.
Facial muscles are thin, small, and many of them attach into the SMAS rather than to bone, which is why a contraction becomes an expression rather than a movement. The anatomy is different enough that the transfer has to be demonstrated rather than assumed.
So when a brand cites athletes, astronauts or physiotherapy as evidence for a facial device, the citation is doing rhetorical work rather than evidential work. The mechanism is shared; the outcome is not established by association.
What the facial evidence actually says
There is facial-specific research and it is worth reading on its own terms. Kavanagh and colleagues followed 108 women through 12 weeks of motor-level facial stimulation and measured an 18.6 percent increase in cheek muscle thickness (10.1111/jocd.12007).
Chang and colleagues ran a double-blind sham-controlled trial on facial stimulation (10.3390/ijerph17113783), and Kwak and colleagues used a split-face design (10.52660/jksc.2023.29.6.1505).
Those are studies of the category under defined protocols, not trials of any consumer device, ours included. That is the correct claim and it is a smaller one than the astronaut framing implies.
What the clinical lineage genuinely gives you
A mechanism that is characterised rather than speculative. Nobody is arguing about whether current crosses the motor threshold and produces a contraction; that part is settled physics and physiology.
A long safety record for the underlying principle, applied under supervision, which is not the same as a safety record for any given consumer device but is not nothing either.
A body of work on how stimulation behaves over time. Downey and colleagues tested frequency modulation against constant frequency in a neuromuscular protocol (PMID 21996798), and Papaiordanidou and colleagues report a case where modulation did not help (10.1371/journal.pone.0084740). Both inform how a device should be designed rather than what it will do to your face.
How to read the claim when you see it
If a page says the technology comes from rehabilitation, that is true and unremarkable, since it applies to every EMS device on the market.
If a page implies that a rehabilitation or sports result is a facial result, ask which facial study it is citing. The answer is the test.
Our own devices publish what they deliver: 7 mA at 500 ohms for Face and Pro with a 4 microsecond pulse, 7.7 mA for Pro Edition, 9 mA for Pro Plus and GLOW, cleared under K190269, K230506, K221443 and K243587. Those figures are specific to the devices; the studies above are not.
For more on separating a real study from a marketing statistic, see how to read a facial device study.